189 related articles for article (PubMed ID: 37565164)
1. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
[TBL] [Abstract][Full Text] [Related]
2. Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Ding L; Ning S; Hu W; Xue Y; Yu S
Oxid Med Cell Longev; 2022; 2022():6595989. PubMed ID: 36199423
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9837859. PubMed ID: 37475935
[TBL] [Abstract][Full Text] [Related]
4. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic Cholangiocarcinoma Cells Promote Epithelial-mesenchymal Transition of Hepatocellular Carcinoma Cells by Secreting LAMC2.
Cen W; Li J; Tong C; Zhang W; Zhao Y; Lu B; Yu J
J Cancer; 2021; 12(12):3448-3457. PubMed ID: 33995623
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Expression of Tspan8 in Patients with Intrahepatic Cholangiocarcinoma and Its Relationship with Clinicopathological Features and Prognosis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9834798. PubMed ID: 37387978
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Application Value of Contrast-Enhanced Ultrasound Combined with Enhanced MR Scanning in Patients with Intrahepatic Cholangiocarcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9876728. PubMed ID: 37476736
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Jeong S; Tong Y; Sha M; Gu J; Xia Q
Oncotarget; 2017 Mar; 8(10):17292-17300. PubMed ID: 28030846
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9815950. PubMed ID: 38230074
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9819147. PubMed ID: 37808149
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
[TBL] [Abstract][Full Text] [Related]
12. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
Oncology JO
J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9808126. PubMed ID: 38550199
[TBL] [Abstract][Full Text] [Related]
14. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
[No Abstract] [Full Text] [Related]
15. Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9764352. PubMed ID: 37860436
[TBL] [Abstract][Full Text] [Related]
16. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
Imaging CMM
Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment: Necroptosis Switches the Subtype of Liver Cancer While Necrosis Promotes Tumor Recurrence and Progression.
Özdemir BH
Exp Clin Transplant; 2023 Apr; 21(4):291-298. PubMed ID: 35297332
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Prognostic and Immunological Significance of FUNDC1 in Hepatocellular Carcinoma: A Study on TCGA Mining.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9818549. PubMed ID: 38077877
[TBL] [Abstract][Full Text] [Related]
20. Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Markers D
Dis Markers; 2023; 2023():9806936. PubMed ID: 37502585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
